Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Taube

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Evaluation & the Health Professions|November 3, 1997
The incorporation of empirical item difficulty data into the Angoff standard-setting procedureK T Taube
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 29, 1999
Clodronate as a cause of aminotransferase elevationK Laitinen, T Taube
Lancet (London, England)|March 28, 1981
Cyclophosphamide and suppressor cell functionT Taube, Z Brown, D G Williams
Harefuah|December 1, 1982
[The CO2 laser beam in pediatric plastic surgery]A Sarig, M Ben-Bassat, T Taube, et al.
World Journal of Clinical Oncology|August 10, 2019
Pseudo- or real progression? An ovarian cancer patient under nivolumab: A case reportMona Passler, Eliane T Taube, Jalid Sehouli, et al.
Calcified Tissue International|August 3, 2005
Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric studyT Saarto, T Taube, C Blomqvist, et al.
British Journal of Haematology|September 1, 1992
Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP)T Taube, K Franssila, L Risteli, et al.
Bone|January 1, 1991
Rationale for the use of bisphosphonates in bone metastasesJ A Kanis, E V McCloskey, T Taube, et al.
Current Opinion in Obstetrics & Gynecology|December 10, 2025
Mesothelin in solid tumors: biology, biomarker utility, and therapeutic targetingIlary Ruscito, Elizaveta Baisheva, Eliane T Taube, et al.
European Urology|January 1, 1988
Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapyI Elomaa, T Taube, C Blomqvist, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Evaluation & the Health Professions|November 3, 1997
The incorporation of empirical item difficulty data into the Angoff standard-setting procedureK T Taube
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 29, 1999
Clodronate as a cause of aminotransferase elevationK Laitinen, T Taube
Lancet (London, England)|March 28, 1981
Cyclophosphamide and suppressor cell functionT Taube, Z Brown, D G Williams
Harefuah|December 1, 1982
[The CO2 laser beam in pediatric plastic surgery]A Sarig, M Ben-Bassat, T Taube, et al.
World Journal of Clinical Oncology|August 10, 2019
Pseudo- or real progression? An ovarian cancer patient under nivolumab: A case reportMona Passler, Eliane T Taube, Jalid Sehouli, et al.
Calcified Tissue International|August 3, 2005
Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric studyT Saarto, T Taube, C Blomqvist, et al.
British Journal of Haematology|September 1, 1992
Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP)T Taube, K Franssila, L Risteli, et al.
Bone|January 1, 1991
Rationale for the use of bisphosphonates in bone metastasesJ A Kanis, E V McCloskey, T Taube, et al.
Current Opinion in Obstetrics & Gynecology|December 10, 2025
Mesothelin in solid tumors: biology, biomarker utility, and therapeutic targetingIlary Ruscito, Elizaveta Baisheva, Eliane T Taube, et al.
European Urology|January 1, 1988
Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapyI Elomaa, T Taube, C Blomqvist, et al.
Pageof 7